137 related articles for article (PubMed ID: 10386983)
1. A globin fragment, LVV-hemorphin-7, induces [3H]thymidine incorporation in a neuronal cell line via the AT4 receptor.
Moeller I; Albiston AL; Lew RA; Mendelsohn FA; Chai SY
J Neurochem; 1999 Jul; 73(1):301-8. PubMed ID: 10386983
[TBL] [Abstract][Full Text] [Related]
2. The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain.
Moeller I; Lew RA; Mendelsohn FA; Smith AI; Brennan ME; Tetaz TJ; Chai SY
J Neurochem; 1997 Jun; 68(6):2530-7. PubMed ID: 9166749
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the AT(4) receptor in a human neuroblastoma cell line (SK-N-MC).
Mustafa T; Chai SY; Mendelsohn FA; Moeller I; Albiston AL
J Neurochem; 2001 Mar; 76(6):1679-87. PubMed ID: 11259486
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Lew RA; Mustafa T; Ye S; McDowall SG; Chai SY; Albiston AL
J Neurochem; 2003 Jul; 86(2):344-50. PubMed ID: 12871575
[TBL] [Abstract][Full Text] [Related]
6. Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.
Demaegdt H; Vanderheyden P; De Backer JP; Mosselmans S; Laeremans H; Le MT; Kersemans V; Michotte Y; Vauquelin G
Biochem Pharmacol; 2004 Sep; 68(5):885-92. PubMed ID: 15294451
[TBL] [Abstract][Full Text] [Related]
7. Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.
Lee J; Albiston AL; Allen AM; Mendelsohn FA; Ping SE; Barrett GL; Murphy M; Morris MJ; McDowall SG; Chai SY
Neuroscience; 2004; 124(2):341-9. PubMed ID: 14980384
[TBL] [Abstract][Full Text] [Related]
8. Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats.
Fitzgerald SM; Evans RG; Bergström G; Anderson WP
J Cardiovasc Pharmacol; 1999 Aug; 34(2):206-11. PubMed ID: 10445671
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7.
Lee J; Chai SY; Mendelsohn FA; Morris MJ; Allen AM
Neuropharmacology; 2001 Mar; 40(4):618-23. PubMed ID: 11249971
[TBL] [Abstract][Full Text] [Related]
10. Haemorphin peptides may be endogenous ligands for brain angiotensin AT4 receptors.
Moeller I; Chai SY; Smith I; Lew R; Mendelsohn FA
Clin Exp Pharmacol Physiol Suppl; 1998 Nov; 25():S68-71. PubMed ID: 9809196
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin IV/AT4 receptor.
Chai SY; Fernando R; Peck G; Ye SY; Mendelsohn FA; Jenkins TA; Albiston AL
Cell Mol Life Sci; 2004 Nov; 61(21):2728-37. PubMed ID: 15549174
[TBL] [Abstract][Full Text] [Related]
12. Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography.
Chai SY; Bastias MA; Clune EF; Matsacos DJ; Mustafa T; Lee JH; McDowall SG; Paxinos G; Mendelsohn FA; Albiston AL
J Chem Neuroanat; 2000 Dec; 20(3-4):339-48. PubMed ID: 11207430
[TBL] [Abstract][Full Text] [Related]
13. Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor.
Ali A; Johnstone EKM; Baby B; See HB; Song A; Rosengren KJ; Pfleger KDG; Ayoub MA; Vijayan R
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379211
[TBL] [Abstract][Full Text] [Related]
14. VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides.
Garreau I; Zhao Q; Pejoan C; Cupo A; Piot JM
Neuropeptides; 1995 Apr; 28(4):243-50. PubMed ID: 7596489
[TBL] [Abstract][Full Text] [Related]
15. The hemoglobin derived peptide LVV-hemorphin-7 evokes behavioral effects mediated by oxytocin receptors.
da Cruz KR; Turones LC; Camargo-Silva G; Gomes KP; Mendonça MM; Galdino P; Rodrigues-Silva C; Santos RAS; Costa EA; Ghedini PC; Ianzer D; Xavier CH
Neuropeptides; 2017 Dec; 66():59-68. PubMed ID: 28985964
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.
Demaegdt H; Lenaerts PJ; Swales J; De Backer JP; Laeremans H; Le MT; Kersemans K; Vogel LK; Michotte Y; Vanderheyden P; Vauquelin G
Eur J Pharmacol; 2006 Sep; 546(1-3):19-27. PubMed ID: 16919623
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms.
Albiston AL; Pederson ES; Burns P; Purcell B; Wright JW; Harding JW; Mendelsohn FA; Weisinger RS; Chai SY
Behav Brain Res; 2004 Sep; 154(1):239-43. PubMed ID: 15302130
[TBL] [Abstract][Full Text] [Related]
18. In vivo processing of LVV-hemorphin-7 in rat brain and blood utilizing microdialysis combined with electrospray mass spectrometry.
Nydahl KS; Pierson J; Nyberg F; Caprioli RM; Andrén PE
Rapid Commun Mass Spectrom; 2003; 17(8):838-44. PubMed ID: 12672139
[TBL] [Abstract][Full Text] [Related]
19. LVV-hemorphin-4 modulates Ca2+/calmodulin-dependent pathways in the immune system by the same mechanism as in the brain.
Barkhudaryan N; Gambarov S; Gyulbayazyan T; Nahapetyan K
J Mol Neurosci; 2002 Jun; 18(3):203-10. PubMed ID: 12059038
[TBL] [Abstract][Full Text] [Related]
20. LVV-hemorphin 7 and angiotensin IV in correlation with antinociception and anti-thermal hyperalgesia in rats.
Cheng BC; Tao PL; Cheng YY; Huang EY
Peptides; 2012 Jul; 36(1):9-16. PubMed ID: 22484286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
